Abstract:
Background: Management of dry eye syndrome (DES) is a current medical,
pharmaceutical and social issue both globally and in Ukraine.
Purpose: To assess changes in quantitative characteristics of the Ukrainian market of
tear replacement products (TRPs) for dry eye disease over 2016-2019.
Material and Methods: Data from the national pharmacy-related registers and from
PharmXplorer, a marketing research database from Proxima Research LLC, were used
for research. Sales were assessed in terms of both packages and Ukrainian hryvnias (₴).
Retrospective, structural and graphical methods were used for research.
Results: Of the TRPs available on the market, only 10.7% were Ukrainian products.
Almost half (46.43%) of the TRPs were those whose price range was from ₴101 to ₴200.
The smallest share of the market (14.28%) was attributed to the most expensive TRPs.
In addition, almost half of the products of the lowest price range (₴100 and under) were
domestic products.
Conclusion: the number of domestic TRPs in the Ukrainian pharmaceutical market is
limited. A stable increase in TRP retail sales both in packages and hryvnias indicates a
stable and positive increase in demand for therapeutic products for dry eye patients. A
Ukrainian lowest-price niche medical device containing both dexpanthenol and taurin
was an absolute leader of 2016-2019 TRP retail sales.
